Segui
Joel Giblett
Joel Giblett
Email verificata su cam.ac.uk
Titolo
Citata da
Citata da
Anno
Patent foramen ovale closure in 2019
JP Giblett, O Abdul-Samad, LM Shapiro, BS Rana, PA Calvert
Interventional Cardiology Review 14 (1), 34, 2019
622019
Functional polymorphism in ABCA1 influences age of symptom onset in coronary artery disease patients
T Kyriakou, DE Pontefract, E Viturro, CP Hodgkinson, RC Laxton, ...
Human molecular genetics 16 (12), 1412-1422, 2007
502007
Patent foramen ovale closure: state of the art
JP Giblett, LK Williams, S Kyranis, LM Shapiro, PA Calvert
Interventional Cardiology Review 15, 2020
392020
Glucagon-like peptide-1: a promising agent for cardioprotection during myocardial ischemia
JP Giblett, SJ Clarke, DP Dutka, SP Hoole
JACC: Basic to Translational Science 1 (4), 267-276, 2016
352016
Direct stenting is an independent predictor of improved survival in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction
LM McCormick, AJ Brown, LS Ring, PR Gajendragadkar, SJ Dockrill, ...
European Heart Journal: Acute Cardiovascular Care 3 (4), 340-346, 2014
342014
Percutaneous management of paravalvular leaks
JP Giblett, BS Rana, LM Shapiro, PA Calvert
Nature reviews cardiology 16 (5), 275-285, 2019
332019
Post-infarction ventricular septal defect: percutaneous or surgical management in the UK national registry
JP Giblett, A Matetic, D Jenkins, CY Ng, S Venuraju, T MacCarthy, ...
European heart journal 43 (48), 5020-5032, 2022
292022
Transcatheter treatment of postinfarct ventricular septal defects
JP Giblett, DP Jenkins, PA Calvert
Heart 106 (12), 878-884, 2020
252020
Optical coherence tomography guided percutaneous coronary intervention
FJ Ha, JP Giblett, N Nerlekar, JD Cameron, IT Meredith, NEJ West, ...
Heart, Lung and Circulation 26 (12), 1267-1276, 2017
182017
Glucagon-like peptide-1 derived cardioprotection does not utilize a KATP-channel dependent pathway: mechanistic insights from human supply and demand ischemia studies
JP Giblett, RG Axell, PA White, SJ Clarke, L McCormick, PA Read, ...
Cardiovascular diabetology 15, 1-12, 2016
182016
GLP‐1 is a coronary artery vasodilator in humans
SJ Clarke, JP Giblett, LL Yang, A Hubsch, T Zhao, ...
Journal of the American Heart Association 7 (22), e010321, 2018
162018
Rapid Pacing–Induced Right Ventricular Dysfunction Is Evident After Balloon-Expandable Transfemoral Aortic Valve Replacement
RG Axell, PA White, JP Giblett, L Williams, BS Rana, A Klein, M O’Sullivan, ...
Journal of the American College of Cardiology 69 (7), 903-904, 2017
152017
Cardioprotection for percutaneous coronary intervention—reperfusion quality as well as quantity
JP Giblett, NEJ West, SP Hoole
International journal of cardiology 177 (3), 786-793, 2014
152014
Anatomical plaque and vessel characteristics are associated with hemodynamic indices including fractional flow reserve and coronary flow reserve: A prospective exploratory …
AJ Brown, JP Giblett, MR Bennett, NEJ West, SP Hoole
International Journal of Cardiology 248, 92-96, 2017
142017
Stunning and right ventricular dysfunction is induced by coronary balloon occlusion and rapid pacing in humans: insights from right ventricular conductance catheter studies
RG Axell, JP Giblett, PA White, A Klein, J Hampton‐Til, M O'Sullivan, ...
Journal of the American Heart Association 6 (6), e005820, 2017
142017
Implantation of bioresorbable vascular scaffolds following acute coronary syndrome is associated with reduced early neointimal growth and strut coverage
JP Giblett, AJ Brown, H Keevil, C Jaworski, SP Hoole, NE West
EuroIntervention 12 (6), 724-733, 2016
142016
Remote ischemic conditioning in elective PCI?
JP Giblett, SP Hoole
Journal of cardiovascular pharmacology and therapeutics 22 (4), 310-315, 2017
102017
Adenosine‐Induced Coronary Steal Is Observed in Patients Presenting With ST‐Segment–Elevation Myocardial Infarction
M Aetesam‐ur‐Rahman, AJ Brown, C Jaworski, JP Giblett, TX Zhao, ...
Journal of the American Heart Association 10 (13), e019899, 2021
92021
Cardioprotection for acute MI in light of the CONDI2/ERIC-PPCI trial: new targets needed
JP Giblett, H Bulluck
Interventional Cardiology Review 15, 2020
82020
Comparison of routine versus selective glycoprotein IIb/IIIa inhibitors usage in primary percutaneous coronary intervention (from the British Cardiovascular Interventional Society)
M Orzalkiewicz, J Hodson, CS Kwok, PF Ludman, JP Giblett, S George, ...
The American journal of cardiology 124 (3), 373-380, 2019
82019
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20